BioGenes GmbH is a world-wide acting full-service provider for protein analysis, customised antibodies and immunoassays with strong commitment to quality and service.

The broad of substantial biochemical and immunological experience of our interdisciplinary scientists has made us a leading expert in the development of tailor-made solutions for complex projects required by the biopharmaceutical industry. For universities, institutes and industrial research BioGenes offers routine antibody development to support them in accelerating their research.

BioGenes is the reliable partner for your projects in all areas of quality control, diagnostics and drug discovery, and enables you to improve your development and manufacturing processes or to achieve your R&D goals faster.

Our scientists understand the challenges of immunoassay development, validation, and production, find solutions to maximize their sensitivity and performance, and manage the complete quality control in your specific area. Their extensive antibody know-how allows for complex antibody development. BioGenes has optimized the mouse hybridoma technology to produce monoclonal antibodies with antigen mixtures or small antigen amounts. Polyclonal and monoclonal antibodies developed by BioGenes fulfill highest quality standards.

BioGenes is certified to meet the international requirements and regularities of quality assurance and animal welfare. Successful long-term alliances with biotech and pharmaceutical companies as well as research institutes and universities prove that BioGenes is the partner of choice in the fields of protein analysis.